LONG-TERM IMMUNOMODULATORY EFFECTS OF LYMPHOCYTE-T DEPLETION IN PATIENTS WITH SYSTEMIC-SCLEROSIS

被引:18
作者
GORONZY, JJ [1 ]
WEYAND, CM [1 ]
机构
[1] UNIV HEIDELBERG,DEPT MED 5,DIV RHEUMATOL,W-6900 HEIDELBERG,GERMANY
来源
ARTHRITIS AND RHEUMATISM | 1990年 / 33卷 / 04期
关键词
D O I
10.1002/art.1780330408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe 2 patients with rapidly progressing systemic sclerosis that did not respond to conventional therapy, who were treated with a 5‐day regimen of T cell‐specific antilymphocyte globulin. One patient had deteriorating pulmonary involvement, and the second patient had developed disabling skin disease with multiple ulcers and gangrene. Both patients showed improvement concomitant with almost complete elimination of CD4+ and CD8+ T lymphocytes. Regeneration of peripheral T cells required 60–90 days and was followed by a long‐term inversion of the CD4:CD8 ratio. The persistent therapeutic effect in both patients correlated with the lack of CD4+ T cells and the predominance of CD8+ T cells. This suggests a crucial role of T cell immunity in the pathogenesis of systemic sclerosis. In vitro studies of regenerating T cells demonstrated that CD4+ helper/inducer cells were functionally competent. Alterations in the composition of the CD8+ population may explain the prolonged suppression of CD4+ T cells observed during the period of therapeutic benefit. Copyright © 1990 American College of Rheumatology
引用
收藏
页码:511 / 519
页数:9
相关论文
共 23 条
[1]  
AMENTO E P, 1988, Arthritis and Rheumatism, V31, pS21
[2]   TREATMENT OF CUTANEOUS SCLEROSIS AND APLASTIC-ANEMIA WITH ANTITHYMOCYTE GLOBULIN [J].
BALABAN, EP ;
SHEEHAN, RG ;
LIPSKY, PE ;
FRENKEL, EP .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) :56-58
[3]  
CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
[4]   HUMAN INVIVO ANTIGENIC MODULATION INDUCED BY THE ANTI-T-CELL OKT3 MONOCLONAL-ANTIBODY [J].
CHATENOUD, L ;
BAUDRIHAYE, MF ;
KREIS, H ;
GOLDSTEIN, G ;
SCHINDLER, J ;
BACH, JF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (11) :979-982
[5]  
COSIMI AB, 1981, TRANSPLANT P, V13, P462
[6]  
GOLDRING MB, 1986, J BIOL CHEM, V261, P9049
[7]  
GOLDRING MB, 1987, J BIOL CHEM, V262, P16724
[8]  
GRAY JG, 1966, J IMMUNOL, V96, P217
[9]   THE IMMUNOPATHOLOGY OF PROGRESSIVE SYSTEMIC-SCLEROSIS (PSS) [J].
HAYNES, DC ;
GERSHWIN, ME .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1982, 11 (03) :331-351
[10]   ENDOTHELIAL INJURY IN SCLERODERMA [J].
KAHALEH, MB ;
SHERER, GK ;
LEROY, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (06) :1326-1335